← Leaderboards
William K. Kelly
Yale University
$4,165,697
Attributed
$7,178,482
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,178,482 · 7
By mechanism
R01$4,966,455 · 2
P30$2,212,027 · 5
Top collaborators
- Grace Lu-Yao5 shared
- Hushan Yang5 shared
- Karen E Knudsen3 shared
- Christopher Michael Mcnair2 shared
Most similar at Yale University
Same institution · by research overlap
- Rong Fan$22,943,481
- Kristen Nwanyanwu$1,272,085
- Serena S Spudich$24,977,707
- Carlos M Grilo$23,768,687
- Hugh S Taylor$17,818,952
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsMalignant NeoplasmsResearch PersonnelMonitorClinical ResearchTranslational ResearchMalignant Neoplasm Of ProstateCancer CenterCellsReportingFundingProgramsBaseCollaborationsInvestigator-Initiated TrialLaboratoriesMemberUniversitiesClinical ManagementLeadershipEnsurePeer ReviewPopulation BasedProtocols Documentation
Grant awards (27)
Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer$653,812
R01 · FY2025 · CA
Clinical Protocol and Data Management$454,585
P30 · FY2025 · CA · contact PI
Protocol Review and Monitoring$64,179
P30 · FY2025 · CA · contact PI
Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer$607,916
R01 · FY2024 · CA
Clinical Protocol and Data Management$425,690
P30 · FY2024 · CA · contact PI
Protocol Review and Monitoring$60,101
P30 · FY2024 · CA · contact PI
Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer$626,097
R01 · FY2023 · CA
Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer$596,405
R01 · FY2022 · CA
Prostate Cancer$48,775
P30 · FY2022 · CA · contact PI
Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer$693,113
R01 · FY2021 · CA
Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer$357,405
R01 · FY2021 · CA
Prostate Cancer$48,775
P30 · FY2021 · CA · contact PI
Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer$357,405
R01 · FY2020 · CA
Prostate Cancer$48,775
P30 · FY2020 · CA · contact PI
Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer$346,682
R01 · FY2019 · CA
Clinical Protocol and Data Management$181,876
P30 · FY2019 · CA · contact PI
Prostate Cancer$48,775
P30 · FY2019 · CA · contact PI
Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer$360,198
R01 · FY2018 · CA
Clinical Protocol and Data Management$181,876
P30 · FY2018 · CA · contact PI
Prostate Cancer$48,775
P30 · FY2018 · CA · contact PI
Clinical Protocol and Data Management$11,841
P30 · FY2018 · CA · contact PI
Prostate Cancer$11,841
P30 · FY2018 · CA · contact PI
Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer$367,422
R01 · FY2017 · CA
Shared Resources-Clinical Research Services$138,419
P30 · FY2011 · CA · contact PI
Shared Resources-Clinical Research Services$155,758
P30 · FY2010 · CA · contact PI
Shared Resources-Clinical Research Services$140,993
P30 · FY2009 · CA · contact PI
Shared Resources-Clinical Research Services$140,993
P30 · FY2008 · CA · contact PI